Relmada Therapeutics Inc. (RLMD)
Relmada Therapeutics Statistics
Share Statistics
Relmada Therapeutics has 33.19M shares outstanding. The number of shares has increased by 0% in one year.
Shares Outstanding | 33.19M |
Shares Change (YoY) | 0% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 27.74% |
Shares Floating | 27.81M |
Failed to Deliver (FTD) Shares | 12.32K |
FTD / Avg. Volume | 1.26% |
Short Selling Information
The latest short interest is 1.26M, so 4.16% of the outstanding shares have been sold short.
Short Interest | 1.26M |
Short % of Shares Out | 4.16% |
Short % of Float | 4.97% |
Short Ratio (days to cover) | 4.52 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -0.27. Relmada Therapeutics's PEG ratio is 0.
PE Ratio | 0 |
Forward PE | -0.27 |
PS Ratio | 0 |
Forward PS | null |
PB Ratio | 0.44 |
P/FCF Ratio | -0.3 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Relmada Therapeutics.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.
Current Ratio | 4.45 |
Quick Ratio | 4.45 |
Debt / Equity | 0 |
Debt / EBITDA | - |
Debt / FCF | 0 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $0 |
Employee Count | 17 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -75.21% in the last 52 weeks. The beta is 0.41, so Relmada Therapeutics's price volatility has been higher than the market average.
Beta | 0.41 |
52-Week Price Change | -75.21% |
50-Day Moving Average | 0.31 |
200-Day Moving Average | 0.62 |
Relative Strength Index (RSI) | 43.84 |
Average Volume (20 Days) | 976.97K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | 0 |
Net Income | 0 |
EBITDA | 0 |
EBIT | n/a |
Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 3.86M in cash and 0 in debt, giving a net cash position of 3.86M.
Cash & Cash Equivalents | 3.86M |
Total Debt | 0 |
Net Cash | 3.86M |
Retained Earnings | -640.88M |
Total Assets | 45.82M |
Working Capital | 35.5M |
Cash Flow
In the last 12 months, operating cash flow was -51.76M and capital expenditures 0, giving a free cash flow of -51.76M.
Operating Cash Flow | -51.76M |
Capital Expenditures | 0 |
Free Cash Flow | -51.76M |
FCF Per Share | -1.72 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RLMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for RLMD is $1, which is 244.8% higher than the current price. The consensus rating is "Hold".
Price Target | $1 |
Price Target Difference | 244.8% |
Analyst Consensus | Hold |
Analyst Count | 4 |
Stock Splits
The last stock split was on Sep 30, 2019. It was a backward split with a ratio of 1:4.
Last Split Date | Sep 30, 2019 |
Split Type | backward |
Split Ratio | 1:4 |
Scores
Altman Z-Score | -25.56 |
Piotroski F-Score | 2 |